Skip to main content

Somatizing and Dissociative Disorders

  • Chapter
The Medical Basis of Psychiatry

Abstract

Most patients consulting physicians have a mixture of physical and mental complaints that require careful differential diagnosis. Somatization is the production of recurrent and multiple physical symptoms in excess of any underlying medical disorder. Patients may have well-documented medical diagnoses, but their complaints are excessive or disproportionate in the judgment of the clinician. In DSM-5 the diagnosis of somatization emphasizes the presence of characteristic positive symptoms and signs for the diagnosis, whereas in DSM-IV the emphasis was on the absence of a medical explanation. DSM-5 makes it clear that the clinician is making a judgment about the complaints being excessive rather than on the absence of any medical diagnosis, but with either criterion, the clinician must make a judgment about the underlying medical basis for the complaints. The assessment and treatment of somatizing disorders requires patience and compassion to maintain a therapeutic alliance, and randomized controlled trials show that treatment with antidepressants, cognitive-behavioral therapy, or mindfulness-based therapies reduce health care utilization and subjective distress.

Somatization Disorder is the best-validated prototype of somatizing disorders, so we will use the adjective “somatizing” to specify the group of disorders referred to as “somatoform disorders” in DSM-IV and as “somatic symptom disorders” in DSM-5. Somatization Disorder has been shown to be a chronic and heritable disorder that is clinically manifest with complaints of multiple bodily pains, gastrointestinal, psueudoneurologic symptoms, sexual, and reproductive symptoms. Unfortunately, general medical practitioners found the criteria for Somatization Disorder in DSM-IV to be time-consuming to apply, so for their convenience DSM-5 has introduced an easy-to-use category of Somatic Symptom Disorder that may be diagnosed on the basis of a single somatic complaint that the clinician judges to be excessive, even though much research shows that such subjective judgments are unreliable. Conversion disorders involve acute or chronic loss of voluntary sensorimotor functions, such as psychogenic blindness, paralysis, or tremors, that can be shown to be inconsistent with neuroanatomy and neurophysiology. In DSM-5, conversion disorders may be diagnosed in the absence of a known psychosocial stressor because recent research has shown that the inconsistent neurological signs are a more reliable basis for the diagnosis. In contrast, some somatizing disorders more closely resemble physical phobias (e.g. hypochondriasis) or social phobias (e.g., body dysmorphic disorder).

Dissociative disorders involve the disruption or loss of the integrative mechanisms of consciousness, memory, identity, or perception. Dissociative disorders include amnesia (a disruption of memory), fugue (a disruption of identity), depersonalization (a disruption of perception), and Dissociative Identity Disorder (a disruption of consciousness and identity formerly called Multiple Personality Disorder). In dissociative disorders, transitions between personalities or the onset of amnesic or fugue states are usually precipitated by psychosocial stress like those observed in conversion disorders. Thus both conversion and dissociative disorders are typically precipitated by severe psychosocial stress, but it is often difficult to elicit the relevant history before treatment until the clinician can contact collateral informants. Recent brain imaging results suggest that hyperactivity of the anterior cingulate cortex can actively inhibit motor activity (e.g. psychogenic paralysis), sensory perception (e.g., psychogenic anesthesia), memory (e.g., amnesia), or identity (e.g. fugue) as a defensive response to stressors.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Hallett M, Fahn S, Jankovic J, Lang AE, Cloninger CR, Yudofsky SC. Psychogenic movement disorders. New York: Lippincott Williams & Wilkins; 2005.

    Google Scholar 

  2. Hallett M, Fahn S, Jankovic J, Lang AE, Cloninger CR, Halligan P. Psychogenic movement disorders & other conversion disorders. Cambridge: Cambridge University Press; 2011.

    Google Scholar 

  3. Andersen NL, Eplov LF, Andersen JT, Hjorthoj CR, Birket-Smith M. Health care use by patients with somatoform disorders: a register-based follow-up study. Psychosomatics 2013;54:132–141.

    Article  PubMed  Google Scholar 

  4. Cloninger CR. The origins of DSM and ICD criteria for conversion and somatization disorders. In: Halligan PW, Bass C, Marshall JC, editors. Contemporary approaches to the study of hysteria. Oxford, UK: Oxford University Press; 2001. p. 49–62.

    Google Scholar 

  5. Gatfield PD, Guze SB. Prognosis and differential diagnosis of conversion reactions (a follow-up study). Dis Nerv Syst 1962;23:1–8.

    Google Scholar 

  6. Raskin M, Talbott JA, Meyerson AT. Diagnosis of conversion reactions: predictive value of psychiatric criteria. JAMA 1966;197:102–106.

    Article  Google Scholar 

  7. Guze SB. The diagnosis of hysteria: what are we trying to do? Am J Psychiatry 1967;124:491–498.

    Article  CAS  PubMed  Google Scholar 

  8. Cloninger CR. “Sickly”: treatment of somatization disorder. In: Spitzer RL, First MB, Gibbon M, Williams JBW, editors. Treatment companion to the DSM-IV-TR casebook. Arlington, VA: American Psychiatric Association Publishing; 2004. p. 306–314.

    Google Scholar 

  9. Zubieta JK, Heitzeg MM, Smith YR, Bueller JA, Xu K, Xu Y, Koeppe RA, Stohler CS, Goldman D. COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor. Science 2003;299:1240–1243.

    Article  CAS  PubMed  Google Scholar 

  10. Enoch MA, Xu K, Ferro E, Harris CR, Goldman D. Genetic origins of anxiety in women: a role for a functional catechol-O-methyltransferase polymorphism. Psychiatr Genet 2003;13:33–41.

    Article  PubMed  Google Scholar 

  11. Wise TN, Mann LS. The relationship between somatosensory amplification, alexithymia, and neuroticism. J Psychosom Res 1994;38:515–521.

    Article  CAS  PubMed  Google Scholar 

  12. Cloninger CR. Feeling good: the science of well being. New York: Oxford University Press; 2004.

    Google Scholar 

  13. Cloninger CR, Przybeck TR, Svrakic DM, Wetzel RD. The temperament and character inventory: a guide to its development and use. St. Louis, MO: Washington University Center for Psychobiology of Personality; 1994.

    Google Scholar 

  14. MacLean PD. Brain evolution relating to family, play, and the separation call. Arch Gen Psychiatry 1985;42:405–417.

    Article  CAS  PubMed  Google Scholar 

  15. Papez JW. A proposed mechanism of emotion. Arch Neurol Psychiatr 1937;38:725–743.

    Article  Google Scholar 

  16. Paus T. Primate anterior cingulate cortex: where motor control, drive and cognition interface. Nat Rev Neurosci 2001;2:417–424.

    Article  CAS  PubMed  Google Scholar 

  17. Ongur D, Price JL. The organization of networks within the orbital and medial prefrontal cortex of rats, monkeys and humans. Cereb Cortex 2000;10:207–219.

    Article  Google Scholar 

  18. Paulus MP, Rogalsky C, Simmons A, Feinstein JS, Stein MB. Increased activation in the right insula during risk-taking decision making is related to harm avoidance and neuroticism. NeuroImage 2003;19:1439–1448.

    Article  PubMed  Google Scholar 

  19. Pezawas L, Meyer-Lindenberg A, Drabant EM, Verchinski BA, Munoz KE, Kolachana BS, Egan MF, Mattay VS, Harriri AR, Weinberger DR. 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression. Nat Neurosci 2005;8:828–834.

    Article  CAS  PubMed  Google Scholar 

  20. Pujol J, Lopez A, Deus J, Cardoner N, Vallejo J, Capdevila A, Paus T. Anatomical variability of the anterior cingulate gyrus and basic dimensions of human personality. NeuroImage 2002;15:847–855.

    Article  PubMed  Google Scholar 

  21. Feinberg TE, Keenan JP. The lost self: pathologies of the brain and identity. New York: Oxford University Press; 2005.

    Book  Google Scholar 

  22. Goleman D. Emotional intelligence: why it can matter more than IQ. New York: Bantam; 1995.

    Google Scholar 

  23. Geher G. Measuring emotional intelligence: common ground and controversy. Hauppauge, NY: Nova Science; 2004.

    Google Scholar 

  24. Cloninger CR. Completing the psychobiological architecture of human personality development: temperament, character, & coherence. In: Staudinger UM, Lindenberger UER, editors. Understanding human development: dialogues with lifespan psychology. Boston: Kluwer Academic; 2003. p. 159–182.

    Chapter  Google Scholar 

  25. Baltes PB, Smith J. Toward a psychology of wisdom and its ontogenesis. In: Sternberg RJ, editor. Wisdom: its nature, origins, and development. New York: Cambridge University Press; 1990. p. 87–120.

    Chapter  Google Scholar 

  26. Sternberg RJ. Wisdom and its relations to intelligence and creativity. In: Sternberg RJ, editor. Wisdom: its nature, origins, and development. New York: Cambridge University Press; 1990. p. 142–159.

    Chapter  Google Scholar 

  27. Nemiah JC, Freyberger H, Sifneos PE. Alexithymia: a view of the psychosomatic process. In: Hill OW, editor. Modern trends in psychosomatic medicine. London: Butterworths; 1976. p. 430–439.

    Google Scholar 

  28. Taylor GJ, Bagby RM, Parker JD. Disorders of affect regulation: alexithymia in medical and psychiatric illness. Cambridge, UK: Cambridge University Press; 1997.

    Book  Google Scholar 

  29. Krystal H. Alexithymia and the effectiveness of psychoanalytic treatment. Int J Psychoanal Psychother 1982;9:353–378.

    PubMed  Google Scholar 

  30. Bach M, Bach D. Alexithymia in somatoform disorder and somatic disease: a comparative study. Psychother Psychosom 1996;65:150–152.

    Article  CAS  PubMed  Google Scholar 

  31. Cox BJ, Kuch K, Parker JD, Shulman ID, Evans RJ. Alexithymia in somatoform disorder patients with chronic pain. J Psychosom Res 1994;38:523–527.

    Article  CAS  PubMed  Google Scholar 

  32. Subic-Wrana C, Bruder S, Thomas W, Lane RD, Kohle K. Emotional awareness deficits in inpatients of a psychosomatic ward: a comparison of two different measures of alexithymia. Psychosom Med 2005;67:483–489.

    Article  PubMed  Google Scholar 

  33. Bankier B, Aigner M, Bach M. Alexithymia in DSM-IV disorder: comparative evaluation of somatoform disorder, panic disorder, obsessive-compulsive disorder, and depression. Psychosomatics 2001;42:235–240.

    Article  CAS  PubMed  Google Scholar 

  34. Bagby RM, Taylor GJ, Ryan D. Toronto alexithymia scale: relationship with personality and psychopathology measures. Psychother Psychosom 1986;45:207–215.

    Article  CAS  PubMed  Google Scholar 

  35. Sayar K, Ebrinc S, Ak I. Alexithymia in patients with antisocial personality disorder in a military hospital setting. Isr J Psychiatry Relat Sci 2001;38:81–87.

    CAS  PubMed  Google Scholar 

  36. Shevrin H, Ghannam JH, Libet B. A neural correlate of consciousness related to repression. Conscious Cogn 2002;11:334–341.

    Article  PubMed  Google Scholar 

  37. Sayar K, Gulec H, Topbas M. Alexithymia and anger in patients with fibromyalgia. Clin Rheumatol 2004;23:441–448.

    Article  PubMed  Google Scholar 

  38. Porcelli P, Guidi J, Sirri L, Grandi S, Grassi L, Ottolini F, Pasquini P, Picardi A, Rafanelli C, Rigatelli M, Sonino N, Fava GA. Alexithymia in the medically ill. Analysis of 1190 patients in gastroenterology, cardiology, oncology and dermatology. Gen Hosp Psychiatry 2013;35:444–456.

    Article  Google Scholar 

  39. Stonnington CM, Locke DE, Hsu CH, Ritenbaugh C, Lane RD. Somatization is associated with deficits in affective Theory of Mind. J Psychosom Res 2013;74:479–485.

    Article  PubMed  Google Scholar 

  40. Fjorback LO, Arendt M, Ornbol E, Walach H, Rehfeld E, Schroder A, Fink P. Mindfulness therapy for somatization disorder and functional somatic syndromes: randomized trial with one-year follow-up. J Psychosom Res 2013;74:31–40.

    Article  PubMed  Google Scholar 

  41. Fjorback LO, Carstensen T, Arendt M, Ornbol E, Walach H, Rehfeld E, Fink P. Mindfulness therapy for somatization disorder and functional somatic syndromes: analysis of economic consequences alongside a randomized trial. J Psychosom Res 2013;74:41–48.

    Article  PubMed  Google Scholar 

  42. Fjorback LO. Mindfulness and bodily distress. Dan Med J 2012;59:B4547.

    PubMed  Google Scholar 

  43. Dokucu M, Cloninger CR. Somatoform and undifferentiated somatoform disorder. In: Gabbard GO, editor. Treatment of mental disorders. Arlington, VA: American Psychiatric Association Publishing; 2007. p. 431–441.

    Google Scholar 

  44. Halligan PW, Bass C, Marshall JC. Contemporary approaches to the study of hysteria. Oxford: Oxford University Press; 2001.

    Google Scholar 

  45. Abravanel ED, Morrison EK. Dr. Abravanel’s body type diet and lifetime nutrition plan. New York: Bantam; 1999.

    Google Scholar 

  46. Rosenberg MB. Non-violent communication: a language of compassion. Del Mar, CA: PuddleDancer; 1999.

    Google Scholar 

  47. Gottman JM, Gottman JS, DeClaire J. 10 lessons to transform your marriage. New York: Crown; 2006.

    Google Scholar 

  48. Cloninger CR. The happy life: voyages to well-being. St. Louis: Anthropaideia Foundation; 2006.

    Google Scholar 

  49. Whiting P, Bagnall AM, Sowden AJ, Cornell JE, Mulrow C, Ramirez G. Interventions for the treatment and management of chronic fatigue syndrome: a systematic review. JAMA 2001;286:1360–1368.

    Article  CAS  PubMed  Google Scholar 

  50. Servan-Schreiber D. Healing without Freud or Prozac. London: Rodale International; 2005.

    Google Scholar 

  51. Kashner TM, Rost K, Cohen B, Anderson M, Smith GRJ. Enhancing the health of somatization disorder patients: effectiveness of short-term group therapy. Psychosomatics 1995;36:462–470.

    Article  CAS  PubMed  Google Scholar 

  52. Guze SB, Cloninger CR, Martin RL, Clayton PJ. A follow-up and family study of Briquet’s syndrome. Br J Psychiatry 1986;149:17–23.

    Article  CAS  PubMed  Google Scholar 

  53. Cloninger CR, Reich T, Guze SB. The multifactorial model of disease transmission: III Familial relationship between sociopathy and hysteria (Briquet’s syndrome). Br J Psychiatry 1975;127:23–32.

    Article  CAS  PubMed  Google Scholar 

  54. Briquet P. Traite clinique et therapeutique a l’hysterie. Paris: J-B Balliere & Fils; 1859.

    Google Scholar 

  55. Cloninger CR, Sigvardsson S, von Knorring AL, Bohman M. An adoption study of somatoform disorders: II. Identification of two discrete somatoform disorders. Arch Gen Psychiatry 1984;41:863–871.

    Article  CAS  PubMed  Google Scholar 

  56. Smith GRJ, Monson RA, Ray DC. Psychiatric consultation in somatization disorder: a randomized controlled trial. N Engl J Med 1986;314:1407–1413.

    Article  PubMed  Google Scholar 

  57. Kroenke K, Swindle R. Cognitive-behavioral therapy for somatization and symptom syndromes: a critical review of controlled clinical trials. Psychother Psychosom 2000;69:205–215.

    Article  CAS  PubMed  Google Scholar 

  58. Allen LA, Woolfolk RL, Escobar JI, Gara MA, Hamer RM. Cognitive-behavioral therapy for somatization disorder: a randomized controlled trial. Arch Intern Med 2006;166:1512–1518.

    Article  PubMed  Google Scholar 

  59. Kennedy TM, Chalder T, McCrone P, Darnley S, Knapp M, Jones RH, Wessely S. Cognitive behavioral therapy in addition to antispasmodic therapy for irritable bowel syndrome in primary care: randomized controlled trial. Health Technol Assess 2006;10:iii–iv,ix–x,1–67.

    Google Scholar 

  60. Regier DA, Narrow WE, Clarke DE, Kraemer HC, Kuramoto SJ, Kuhl EA, Kupfer DJ. DSM-5 field trials in the United States and Canada, Part II: test-retest reliability of selected categorical diagnoses. Am J Psychiatry 2013;170:59–70.

    Article  PubMed  Google Scholar 

  61. Reid S, Crayford T, Richards S, Nimnuan C, Hotopf M. Recognition of medically unexplained symptoms – do doctors agree? J Psychosom Res 1999;47:483–485.

    Article  CAS  PubMed  Google Scholar 

  62. Johnson SK, DeLuca J, Natelson BH. Assessing somatization disorder in the chronic fatigue syndrome. Psychosom Med 1996;58:50–57.

    Article  CAS  PubMed  Google Scholar 

  63. Rief W, Broadbent E. Explaining medically unexplained symptoms-models and mechanisms. Clin Psychol Rev 2007;27:821–841.

    Article  PubMed  Google Scholar 

  64. Henningsen P, Zimmermann T, Sattel H. Medically unexplained physical symptoms, anxiety, and depression: a meta-analytic review. Psychosom Med 2003;65:528–533.

    Article  PubMed  Google Scholar 

  65. Craig TK, Boardman AP. ABC of mental health. Common mental health problems in primary care. BMJ 1997;314:1609–1612.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  66. Allen LA, Escobar JI, Lehrer PM, Gara MA, Woolfolk RL. Psychosocial treatments for multiple unexplained physical symptoms: a review of the literature. Psychosom Med 2002;64:939–950.

    PubMed  Google Scholar 

  67. Lang AE. General overview of psychogenic movement disorders: epidemiology, diagnosis, and prognosis. In: Hallett M, Fahn S, Jankovic J, Lang AE, Cloninger CR, Yudofsky SC, editors. Psychogenic movement disorders. Philadelphia: Lippincott Williams & Wilkins; 2006. p. 35–41.

    Google Scholar 

  68. Fink GR, Halligan PW, Marshall JC. Neuroimaging in hysteria. In: Hallett M, Fahn S, Jankovic J, Lang AE, Cloninger CR, Yudofsky SC, editors. Psychogenic movement disorders. Philadelphia: Lippincott Williams & Wilkins; 2006. p. 230–237.

    Google Scholar 

  69. Blumer D, Heilbronn M. Chronic pain as a variant of depression disease: the pain-prone disorder. J Nerv Ment Dis 1982;170:381–406.

    Article  CAS  PubMed  Google Scholar 

  70. Phillips KA, Dufresne RG. Body dysmorphic disorder: a guide for dermatologists and cosmetic surgeons. Am J Clin Dermatol 2000;1:235–243.

    Article  CAS  PubMed  Google Scholar 

  71. Phillips KA. Body dysmorphic disorder: clinical aspects and treatment strategies. Bull Menn Clin 1998;62:A33–A48.

    CAS  Google Scholar 

  72. Gillespie R. Hypochondria: its definition, nosology, and psychopathology. Guys Hosp Rep 1928;78:408–460.

    Google Scholar 

  73. Kenyon F. Hypochondriacal states. Br J Psychiatry 1976;129:1–14.

    Article  CAS  PubMed  Google Scholar 

  74. Cloninger CR, von Knorring AL, Sigvardsson S, Bohman M. Symptom patterns and causes of somatization in men. II. Genetic and environmental independence from somatization in women. Genet Epidemiol 1986;3:171–185.

    Article  CAS  PubMed  Google Scholar 

  75. Ross CA, Ness L. Symptom patterns in dissociative identity disorder patients and the general population. J Trauma Dissociation 2013;11:458–468.

    Article  Google Scholar 

  76. Ross CA. Dissociative identity disorder. Curr Psychosis TherTher Rep 2006;4:112–116.

    Article  Google Scholar 

  77. McHugh PR, Putnam FW. Resolved: multiple personality disorder is an individually and socially created artifact. J Am Acad Child Adolesc Psychiatry 1995;34:957–962. discussion 962–963.

    Article  CAS  PubMed  Google Scholar 

  78. Nathan D. Sybil exposed. New York: Free Press (Simon & Schuster); 2011.

    Google Scholar 

  79. Janet P. The major symptoms of hysteria. New York: Macmillan; 1917.

    Google Scholar 

  80. Freud S. A general introduction to psychoanalysis. Garden City, New York: Garden City Publishing Company; 1938.

    Google Scholar 

  81. Cloninger CR, Cloninger KM. Person-centered therapeutics. Int J Pers Cent Med 2011;1:43–52.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C. Robert Cloninger M.D., Ph.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Science+Business Media New York

About this chapter

Cite this chapter

Cloninger, C.R., Dokucu, M. (2016). Somatizing and Dissociative Disorders. In: Fatemi, S., Clayton, P. (eds) The Medical Basis of Psychiatry. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-2528-5_11

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-2528-5_11

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-2527-8

  • Online ISBN: 978-1-4939-2528-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics